SCHEMBL18159532

SCHEMBL18159532

c1ccc(-c2ccc3oc4ccc(-c5ccc6oc7ccc(-c8ccccc8)c8cccc(c9cccc5c69)c78)c5cccc(c6cccc2c36)c45)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.37
CDC14B O60729 1/20 0.37
CDC14A Q9UNH5 1/20 0.37
ABCG2 Q9UNQ0 3/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
MAPK3 P27361 1/20 0.37
AHR P35869 1/20 0.37
PAX8 Q06710 1/20 0.37
WEE1 P30291 1/20 0.36
CTRC Q99895 2/20 0.36
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 2/20 0.34
HPGD P15428 2/20 0.34
MAOA P21397 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16801040 0.98 PARP1 (0.38) PARP1CDC14BCDC14AABCG2CYP1A1
SCHEMBL18159553 0.96 PLA2G2A (0.37) PARP1CDC14BCDC14AABCG2CYP1A1
SCHEMBL16801265 0.92 CRHBP (0.37) PARP1CDC14BCDC14AABCG2CYP1A1
SCHEMBL16801269 0.91 ALDH1A1 (0.44) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL16801073 0.91 ALDH1A1 (0.40) PARP1CDC14BCDC14AABCG2CYP1A1
SCHEMBL16801322 0.90 WEE1 (0.35) PARP1CDC14BCDC14AABCG2CYP1A1
SCHEMBL18159535 0.89 PLA2G2A (0.37) PARP1ABCG2CYP1A1CYP1A2FYN
SCHEMBL21226907 0.89 PLA2G2A (0.37) PARP1CDC14BCDC14AABCG2CYP1A1
SCHEMBL18159559 0.87 PLA2G2A (0.41) PARP1ABCG2CYP1A1CYP1A2FYN
SCHEMBL16801324 0.87 PLA2G2A (0.38) PARP1ABCG2CYP1A1CYP1A2FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
US-10374170-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 PARP1 863/4885CDC14B 4190/4885CDC14A 3706/4885
US-10374170-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 PARP1 863/4885CDC14B 4190/4885CDC14A 3706/4885
US-20160308146-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 PARP1 863/4885CDC14B 4190/4885CDC14A 3706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.